Your browser doesn't support javascript.
loading
A B7-CD28 family based signature demonstrates significantly different prognoses and tumor immune landscapes in lung adenocarcinoma.
Zheng, Shanbo; Luo, Xiaoyang; Dong, Chuanpeng; Zheng, Difan; Xie, Juntao; Zhuge, Lingdun; Sun, Yihua; Chen, Haiquan.
Afiliación
  • Zheng S; Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Luo X; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Dong C; Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Zheng D; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Xie J; Department of BioHealth Informatics, School of Informatics and Computing, Indiana University, Indianapolis, IN.
  • Zhuge L; Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, IN.
  • Sun Y; Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Chen H; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Int J Cancer ; 143(10): 2592-2601, 2018 11 15.
Article en En | MEDLINE | ID: mdl-30152019

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antígenos CD28 / Antígenos B7 / Adenocarcinoma del Pulmón Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Cancer Año: 2018 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antígenos CD28 / Antígenos B7 / Adenocarcinoma del Pulmón Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Cancer Año: 2018 Tipo del documento: Article País de afiliación: China